Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baur, A. S.
Right arrow Articles by Chaubert, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baur, A. S.
Right arrow Articles by Chaubert, P.
Related Collections
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 94 No. 5 (September 1), 1999: pp. 1773-1781

Frequent Methylation Silencing of p15INK4b (MTS2) and p16INK4a (MTS1) in B-Cell and T-Cell Lymphomas

Audrey S. Baur, Phil Shaw, Nathalie Burri, Françoise Delacrétaz, Fred T. Bosman, and Pascal Chaubert

From Institut Universitaire de Pathologie, Lausanne, Switzerland.

The methylation status of p15INK4b (MTS2), p16INK4a (MTS1) and p14ARF (p16beta ) was analyzed in 56 lymphomas by restriction-enzyme related polymerase chain reaction (PCR) (REP), methylation-specific PCR (MSP), and bisulfite genomic sequencing (BGS). Methylation of the p15 and p16 genes was detected, respectively, in 64% and 32% of the B-cell lymphomas, in 44% and 22% of the T-cell lymphomas, and in none of the 5 reactive lymph nodes analyzed. Both p15 and p16 genes were methylated more often in the high-grade (78% and 50%, respectively) than in the low-grade B-cell lymphomas (55% and 21%, respectively). For 5 cases, mapping of the methylated CpGs of the p16 promoter region confirmed the results of REP and MSP. In addition, a large variation in the methylation patterns of p16 exon 1 was observed, not only from one lymphoma to another, but also within a given tumor. Methylation of p15 and p16 was associated with an absence of gene expression, as assessed by reverse transcription-PCR. The p14 gene was unmethylated and normally expressed in all 56 tumors. We found no mutations of p15, p16, or p14 in any of the 56 lymphomas. Our results suggest a role for p15 and p16 gene methylation during lymphomagenesis and a possible association between p15 and p16 inactivation and aggressive transformation in B-cell and T-cell lymphomas.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
R. Zhou, L. Han, G. Li, and T. Tong
Senescence delay and repression of p16INK4a by Lsh via recruitment of histone deacetylases in human diploid fibroblasts
Nucleic Acids Res., June 26, 2009; (2009) gkp533v1.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
K. Amara, M. Trimeche, S. Ziadi, A. Laatiri, M. Hachana, and S. Korbi
Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas
Ann. Onc., October 1, 2008; 19(10): 1774 - 1786.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
L. Fini, M. Selgrad, V. Fogliano, G. Graziani, M. Romano, E. Hotchkiss, Y. A. Daoud, E. B. De Vol, C. R. Boland, and L. Ricciardiello
Annurca Apple Polyphenols Have Potent Demethylating Activity and Can Reactivate Silenced Tumor Suppressor Genes in Colorectal Cancer Cells
J. Nutr., December 1, 2007; 137(12): 2622 - 2628.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. R. L. Young, C. Mumaw, J. A. Marrs, and D. G. Skalnik
Antisense Targeting of CXXC Finger Protein 1 Inhibits Genomic Cytosine Methylation and Primitive Hematopoiesis in Zebrafish
J. Biol. Chem., December 1, 2006; 281(48): 37034 - 37044.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
N. Takai, N. Kawamata, C. S. Walsh, S. Gery, J. C. Desmond, S. Whittaker, J. W. Said, L. M. Popoviciu, P. A. Jones, I. Miyakawa, et al.
Discovery of Epigenetically Masked Tumor Suppressor Genes in Endometrial Cancer
Mol. Cancer Res., May 1, 2005; 3(5): 261 - 269.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. Gemmati, A. Ongaro, G. L. Scapoli, M. Della Porta, S. Tognazzo, M. L. Serino, E. Di Bona, F. Rodeghiero, G. Gilli, R. Reverberi, et al.
Common Gene Polymorphisms in the Metabolic Folate and Methylation Pathway and the Risk of Acute Lymphoblastic Leukemia and non-Hodgkin's Lymphoma in Adults
Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 787 - 794.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Takahashi, N. Shivapurkar, J. Reddy, H. Shigematsu, K. Miyajima, M. Suzuki, S. Toyooka, S. Zochbauer-Muller, J. Drach, G. Parikh, et al.
DNA Methylation Profiles of Lymphoid and Hematopoietic Malignancies
Clin. Cancer Res., May 1, 2004; 10(9): 2928 - 2935.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Yang, C.-M. Chen, P. Yan, T. H-M. Huang, H. Shi, M. Burger, I. Nimmrich, S. Maier, K. Berlin, and C. W. Caldwell
The Androgen Receptor Gene is Preferentially Hypermethylated in Follicular Non-Hodgkin's Lymphomas
Clin. Cancer Res., September 15, 2003; 9(11): 4034 - 4042.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Sanchez-Beato, A. Sanchez-Aguilera, and M. A. Piris
Cell cycle deregulation in B-cell lymphomas
Blood, February 15, 2003; 101(4): 1220 - 1235.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. J. Garcia, B. Martinez-Delgado, A. Cebrian, A. Martinez, J. Benitez, and C. Rivas
Different Incidence and Pattern of p15INK4b and p16INK4a Promoter Region Hypermethylation in Hodgkin's and CD30-Positive Non-Hodgkin's Lymphomas
Am. J. Pathol., September 1, 2002; 161(3): 1007 - 1013.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. McGregor, A. Muntoni, J. Fleming, J. Brown, D. H. Felix, D. G. MacDonald, E. K. Parkinson, and P. R. Harrison
Molecular Changes Associated with Oral Dysplasia Progression and Acquisition of Immortality: Potential for Its Reversal by 5-Azacytidine
Cancer Res., August 15, 2002; 62(16): 4757 - 4766.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. L. Ping Siu, J. K. Cheung Chan, K.-F. Wong, and Y.-L. Kwong
Specific Patterns of Gene Methylation in Natural Killer Cell Lymphomas : p73 Is Consistently Involved
Am. J. Pathol., January 1, 2002; 160(1): 59 - 66.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J.-Y. Fang, J. A. Mikovits, R. Bagni, C. L. Petrow-Sadowski, and F. W. Ruscetti
Infection of Lymphoid Cells by Integration-Defective Human Immunodeficiency Virus Type 1 Increases De Novo Methylation
J. Virol., October 15, 2001; 75(20): 9753 - 9761.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Nakamura, T. Sakaki, H. Hashimoto, H. Nakase, E. Ishida, K. Shimada, and N. Konishi
Frequent Alterations of the p14ARF and p16INK4a Genes in Primary Central Nervous System Lymphomas
Cancer Res., September 1, 2001; 61(17): 6335 - 6339.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Sanchez-Beato, A. I. Saez, I. C. Navas, P. Algara, M. Sol Mateo, R. Villuendas, F. Camacho, A. Sanchez-Aguilera, E. Sanchez, and M. A. Piris
Overall Survival in Aggressive B-Cell Lymphomas Is Dependent on the Accumulation of Alterations in p53, p16, and p27
Am. J. Pathol., July 1, 2001; 159(1): 205 - 213.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Matsuo, R. Suzuki, N. Hamajima, M. Ogura, Y. Kagami, H. Taji, E. Kondoh, S. Maeda, S. Asakura, S. Kaba, et al.
Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma
Blood, May 15, 2001; 97(10): 3205 - 3209.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Pinyol, L. Hernandez, A. Martinez, F. Cobo, S. Hernandez, S. Bea, A. Lopez-Guillermo, I. Nayach, A. Palacin, A. Nadal, et al.
INK4a/ARF Locus Alterations in Human Non-Hodgkin's Lymphomas Mainly Occur in Tumors with Wild-Type p53 Gene
Am. J. Pathol., June 1, 2000; 156(6): 1987 - 1996.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
I. C. Navas, P. L. Ortiz-Romero, R. Villuendas, P. Martinez, C. Garcia, E. Gomez, J. L. Rodriguez, D. Garcia, F. Vanaclocha, L. Iglesias, et al.
p16INK4a Gene Alterations Are Frequent in Lesions of Mycosis Fungoides
Am. J. Pathol., May 1, 2000; 156(5): 1565 - 1572.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. Melendez, M. Malumbres, I. P. de Castro, J. Santos, A. Pellicer, and J. Fernandez-Piqueras
Characterization of the murine p19ARF promoter CpG island and its methylation pattern in primary lymphomas
Carcinogenesis, April 1, 2000; 21(4): 817 - 821.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1999 by American Society of Hematology         Online ISSN: 1528-0020